PURE Bioscience reports fiscal third quarter 2014 financial results
date:Jun 12, 2014
quarter operating results are in line with our expectations of completing the manufacturing technology transfer and initiating out-sourced production and distribution to our QSR market test and other customers, stated Peter C. Wulff, Chief Financial Officer and Chief Operating Officer. We believe we are well positioned with our new operating structure to meet expected market demand.
4/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/10 03:30